Genenta Science Financials
| GNTA Stock | USD 4.78 0.01 0.21% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.21 | 12.2469 |
|
|
The financial analysis of Genenta Science is a critical element in measuring its lifeblood. Investors should not minimize Genenta Science's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Genenta | Select Account or Indicator |
Understanding current and past Genenta Science Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Genenta Science's financial statements are interrelated, with each one affecting the others. For example, an increase in Genenta Science's assets may result in an increase in income on the income statement.
Please note, the presentation of Genenta Science's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Genenta Science's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Genenta Science's management manipulating its earnings.
Genenta Science Stock Summary
Genenta Science competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company was incorporated in 2014 and is headquartered in Milan, Italy. Genenta Science is traded on NASDAQ Exchange in the United States.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US36870W1009 |
| CUSIP | 36870W100 |
| Location | Italy |
| Business Address | Via Olgettina No |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.genenta.com |
| Phone | 39 02 26 43 46 81 |
| Currency | USD - US Dollar |
Genenta Science Key Financial Ratios
| Return On Equity | -0.43 | ||||
| EBITDA | (11.69 M) | ||||
| Net Income | (11.65 M) | ||||
| Cash Per Share | 2.04 X | ||||
| Current Ratio | 34.15 X |
Genenta Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genenta Science's current stock value. Our valuation model uses many indicators to compare Genenta Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genenta Science competition to find correlations between indicators driving Genenta Science's intrinsic value. More Info.Genenta Science SpA is rated # 2 in return on equity category among its peers. It is rated # 3 in return on asset category among its peers . At present, Genenta Science's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genenta Science's earnings, one of the primary drivers of an investment's value.Genenta Science SpA Systematic Risk
Genenta Science's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Genenta Science volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Genenta Science SpA correlated with the market. If Beta is less than 0 Genenta Science generally moves in the opposite direction as compared to the market. If Genenta Science Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Genenta Science SpA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Genenta Science is generally in the same direction as the market. If Beta > 1 Genenta Science moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Genenta Science Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Genenta Science's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Genenta Science growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Genenta Science November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Genenta Science help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genenta Science SpA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genenta Science SpA based on widely used predictive technical indicators. In general, we focus on analyzing Genenta Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genenta Science's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.76 | |||
| Information Ratio | 0.048 | |||
| Maximum Drawdown | 39.54 | |||
| Value At Risk | (9.87) | |||
| Potential Upside | 11.19 |
Complementary Tools for Genenta Stock analysis
When running Genenta Science's price analysis, check to measure Genenta Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genenta Science is operating at the current time. Most of Genenta Science's value examination focuses on studying past and present price action to predict the probability of Genenta Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genenta Science's price. Additionally, you may evaluate how the addition of Genenta Science to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |